There is a newer version
of
this Section
2017 Idaho Statutes
Title 54 - PROFESSIONS, VOCATIONS, AND BUSINESSES
Chapter 17 - PHARMACISTS
Section 54-1770 - NOTIFICATION OF DRUG PRODUCT SELECTION FOR EPILEPSY AND SEIZURE DRUGS.
Universal Citation: ID Code § 54-1770 (2017)
54-1770. notification of drug product selection for epilepsy and seizure drugs. (1) In this section:
(a) "Anti-epileptic drug" means:
(i) A drug used for the treatment of epilepsy; or
(ii) A drug used to treat or prevent seizures.
(b) "Drug product selection" means the selection of a therapeutically equivalent drug, including a generic version for the prescribed brand, a branded version for the prescribed generic, a generic version by one (1) manufacturer for a generic version by a different manufacturer.
(c) "Epilepsy" means a neurological condition characterized by recurrent seizures.
(d) "Seizure" means an acute clinical change secondary to a brief disturbance in the electrical activity of the brain.
(2) When a prescriber has specified that a drug is prescribed for the treatment of epilepsy or seizures, pharmacy personnel who perform drug product selections shall:
(a) Notify the prescriber of such drug product selection via facsimile, telephone message or any other appropriate means to the prescriber’s place of business; and
(b) Provide the patient or the patient’s representative with notification of the selection.
(3) Nothing in this section shall delay the dispensing of a valid prescription for an anti-epileptic drug.
History:
[54-1770, added 2010, ch. 277, sec. 1, p. 717.]
Disclaimer: These codes may not be the most recent version. Idaho may have more current or accurate information. We make no warranties or guarantees about the accuracy, completeness, or adequacy of the information contained on this site or the information linked to on the state site. Please check official sources.
This site is protected by reCAPTCHA and the Google
Privacy Policy and
Terms of Service apply.
